tm
Seeing Is Believing
tm
Seeing Is Believing
with an average price target of $2.35. This is a potential upside of $2.35 (0%) from yesterday's end of day stock price of $0.
Adagio Therapeutics's activity chart (see below) currently has 13 price targets and 13 ratings on display.
Analysts average stock forecasts to be materialized ratio is 64.58% with an average time for these price targets to be met of 16.25 days.
Most recent stock forecast was given by MATTHEW HARRISON from MORGAN STANLEY on 17-May-2022. First documented stock forecast 31-Aug-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell Since 13-Jan-2022
3 years 9 months 12 days ago
(17-May-2022)
3/4 (75%)
$-0.12 (-1.96%)
12
Hold Since 15-Dec-2021
$5
$1.52 (43.68%)
$9
3 years 9 months 16 days ago
(13-May-2022)
1/3 (33.33%)
$2.28 (83.82%)
1
Hold Since 28-Dec-2021
$10
4 years 2 months 1 days ago
(28-Dec-2021)
1/2 (50%)
$1.09 (12.23%)
49
Hold Since 16-Dec-2021
$40
4 years 2 months 13 days ago
(16-Dec-2021)
1/1 (100%)
$6.16 (18.20%)
3
What is ADGI (Adagio Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on ADGI (Adagio Therapeutics) with a proven track record?
Which analyst has the current lower performing score on ADGI (Adagio Therapeutics) with a proven track record?
Which analyst has the most public recommendations on ADGI (Adagio Therapeutics)?
Which analyst is the currently most bullish on ADGI (Adagio Therapeutics)?
Which analyst is the currently most reserved on ADGI (Adagio Therapeutics)?
